Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pimasertib + Gemcitabine in Metastatic Pancreatic Cancer
NCT01016483Phase 2Completed
- Sponsor
- EMD Serono
- Start
- Nov 2009
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of pimasertib in pancreatic adenocarcinoma (PDAC), sponsored by EMD Serono. Started Nov 2009; status: completed.
02
Drugs
pimasertib
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT01016483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01016483.